Recombinant Arachis hypogaea 33.0 kDa cold shock protein

What is Arachis hypogaea 33.0 kDa cold shock protein and how does it compare to other cold shock proteins?

Arachis hypogaea 33.0 kDa cold shock protein (AHCSP33) is a stress-responsive protein expressed in peanut plants under cold temperature conditions. Like other cold shock proteins, it likely functions as an RNA chaperone that facilitates mRNA translation during cold stress by preventing the formation of secondary structures in mRNA .

Structurally, cold shock proteins typically contain conserved RNA-binding domains known as cold shock domains (CSDs). Similar proteins like RBM3 bind to specific mRNAs and enhance their translation during cold stress conditions, as demonstrated in mammalian systems . The molecular mechanisms involve both evasion of translational elongation repression and selective enhancement of translation initiation.

How are cold shock proteins classified and what cellular pathways do they regulate?

Cold shock proteins are classified based on their structural domains and molecular weights. They regulate multiple cellular pathways including:

Research on mammalian cold shock proteins has shown they can bind to specific mRNAs (like RTN3 in the case of RBM3) and drive their expression through both trans-acting effects on initiation and enabling escape from translation elongation repression .

What expression systems are optimal for producing recombinant Arachis hypogaea cold shock protein?

The optimal expression system depends on your research requirements:

As noted in product information, this protein can be produced in E. coli, yeast, baculovirus, or mammalian cell systems . For functional studies requiring native-like protein, insect or mammalian systems may be preferable, while structural studies might benefit from the higher yields in bacterial systems.

How can cold-shock induction be used to improve recombinant protein solubility?

Cold-shock induction significantly improves recombinant protein solubility by:

• Reducing the rate of protein synthesis, allowing more time for proper folding

• Inducing expression of endogenous cold shock proteins that act as chaperones

• Decreasing the formation of inclusion bodies

For implementation:

• Grow bacterial culture at standard temperature (37°C) until reaching optimal density

• Reduce temperature to 15-20°C before induction

• Add inducer (e.g., IPTG) at lower concentration than standard protocols

• Continue expression for an extended period (overnight to 24 hours)

This approach has been shown to keep recombinant proteins out of inclusion bodies by slowing down translation elongation rates, thereby providing sufficient time for proper protein folding . The mechanism mirrors natural cold adaptation processes where translational reprogramming occurs.

What methodologies are most effective for studying the RNA-binding properties of cold shock proteins?

Several complementary techniques are recommended for comprehensive analysis:

As demonstrated in studies with related cold shock proteins, immunoprecipitation followed by RNA analysis can effectively detect binding to specific mRNAs (like RBM3 binding to RTN3 mRNA) . For functional consequences, reporter assays using the 5' UTR of potential target mRNAs can demonstrate translational enhancement effects.

How does temperature affect the structure and function of cold shock proteins?

Temperature effects on cold shock proteins involve multiple parameters:

• Structural changes:

  • Increased flexibility of RNA-binding domains at lower temperatures

  • Temperature-dependent conformational changes that enhance RNA binding

• Functional adaptations:

  • Enhanced RNA chaperone activity specifically at lower temperatures

  • Selective binding to mRNAs containing specific motifs in their 5' UTRs

  • Ability to overcome translation elongation blocks induced by cooling

• Expression regulation:

  • Post-transcriptional upregulation during cooling without corresponding increases in mRNA levels

  • Escape from cooling-induced translational repression

How can Arachis hypogaea cold shock protein be used as a tool for enhancing recombinant protein expression?

The protein can be utilized in several ways to enhance recombinant protein expression:

• As a fusion partner:

  • Clone target protein sequence downstream of AHCSP33

  • The cold shock protein domain improves solubility and prevents aggregation

  • Can increase expression yield by 2-5 fold for difficult-to-express proteins

• As a co-expression partner:

  • Express AHCSP33 alongside target protein in the same cell

  • Acts as a molecular chaperone to assist proper folding

  • Particularly effective for proteins prone to misfolding

• In cold-shock expression protocols:

  • Implement temperature downshift during expression

  • AHCSP33 knowledge informs optimal conditions for cold-shock induction

  • Design expression vectors with cold-responsive elements

Implementation requires vector design with appropriate linkers and protease cleavage sites if fusion tags need subsequent removal. The cold shock protein's RNA chaperone activity may also enhance translation of the target protein mRNA, particularly under stress conditions.

What are the methodological approaches for investigating cold shock protein-mediated neuroprotection?

Based on research with related cold shock proteins like RBM3 and RTN3, several methodological approaches are recommended:

Research has demonstrated that cold shock proteins like RBM3 protect against neurodegeneration by preserving synaptic plasticity. RTN3, whose expression is driven by RBM3, has been shown to prevent synaptic loss in mouse models of prion disease . Experimental designs should include both gain-of-function (overexpression) and loss-of-function (knockdown) approaches to establish causal relationships.

What strategies can resolve protein aggregation issues during recombinant expression of cold shock proteins?

Protein aggregation can be addressed through multiple strategies:

• Expression conditions optimization:

  • Lower induction temperature to 15-20°C

  • Reduce inducer concentration to 0.1-0.5 mM IPTG

  • Extend expression time to 16-24 hours

  • Add 2-5% glycerol to growth medium

• Buffer optimization:

  • Include stabilizing additives (glycerol 5-10%, sucrose 5%)

  • Optimize salt concentration (typically 150-300 mM NaCl)

  • Test different pH conditions (typically pH 7.0-8.0)

  • Add low concentrations of non-ionic detergents (0.01-0.05% Tween-20)

• Solubility tag approaches:

  • Use solubility-enhancing fusion partners (MBP, SUMO, thioredoxin)

  • Position tags at N-terminus for better folding progression

Cold-shock conditions specifically help prevent inclusion body formation by slowing down protein synthesis rates, allowing more time for proper folding and chaperone interaction . This resembles the natural response of cells to temperature downshift, where global protein synthesis decreases but certain proteins maintain or increase their synthesis.

How can researchers optimize the purity and yield of cold shock proteins?

Optimization strategies for purity and yield include:

For cold shock proteins specifically, maintaining lower temperatures (4°C) throughout the purification process is critical for preserving functionality. Additionally, inclusion of RNA-binding inhibitors may be necessary if the protein's RNA chaperone activity interferes with purification. Typical yields from optimized E. coli expression systems can reach 10-20 mg of purified protein per liter of culture.

How do different cold shock proteins coordinate their functions during temperature stress response?

Cold shock proteins act in an orchestrated manner through several mechanisms:

• Temporal coordination:

  • Sequential expression patterns with different induction thresholds

  • Early responders activate expression of later components

• Functional specialization:

  • Some proteins focus on transcriptional regulation

  • Others specialize in translational enhancement

  • Some may stabilize cellular structures

• Hierarchical relationships:

  • Master regulators like RBM3 control expression of downstream effectors

  • Secondary effectors like RTN3 mediate specific protective functions

Research has demonstrated that RBM3 acts as an upstream regulator that binds to and drives expression of RTN3 mRNA through both trans-acting effects on initiation and enabling escape from translation elongation repression . This hierarchical relationship suggests a coordinated cold stress response pathway with therapeutic implications for neurodegenerative conditions.

What bioinformatic approaches can identify novel mRNA targets of plant cold shock proteins?

Advanced bioinformatic strategies include:

• Sequence-based prediction:

  • Motif analysis of known binding sites

  • Conservation analysis across species

  • Secondary structure prediction of potential target mRNAs

• Integration of experimental data:

  • Analysis of RIP-seq or CLIP-seq datasets

  • Correlation with translatomic data from polysome profiling

  • Integration with transcriptomic responses to cold stress

• Machine learning approaches:

  • Training models on verified binding sites

  • Feature extraction from RNA sequences and structures

  • Prediction of binding affinity and functional consequences

Implementation requires specialized software packages and careful experimental validation. The analysis of codon usage patterns is particularly relevant, as research has shown that mRNAs that escape cooling-induced translational repression often contain codons requiring less abundant tRNAs in their 5' regions .

What are the emerging applications of cold shock proteins in biotechnology and medicine?

Several promising applications are being developed:

Research has demonstrated significant neuroprotective effects of cold shock proteins like RBM3 and RTN3 in mouse models of prion disease, where these proteins prevented synaptic loss, rescued memory deficits, and significantly prolonged survival . These findings suggest potential therapeutic applications for neurodegenerative conditions like Alzheimer's disease.